Evidence map›Paper›PMID 40362359›Full record

ArticleInternational journal of molecular sciences2025

Photoreactive Properties of Melanin Obtained from Human Induced Pluripotent Stem Cell-Derived Melanocytes.

Krystian Mokrzynski, Mateusz Wojtala, Maciej Sulkowski, Shosuke Ito, Kazumasa Wakamatsu, Andrzej Zadlo, Marcin Majka, Tadeusz Sarna, Michal Sarna

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Pmel17 Deficiency Affects Melanogenesis and Promotes Tumor Vascularization.International journal of molecular sciences · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Krystian MokrzynskiDepartment of Biophysics, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387 Krakow, Poland.ORCID 0000-0001-8092-9132
Mateusz WojtalaDepartment of Biophysics, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387 Krakow, Poland.
Maciej SulkowskiDepartment of Transplantation, Faculty of Clinical Immunology and Transplantation, Institute of Pediatrics, Collegium Medicum Jagiellonian University, Wielicka 265, 30-663 Krakow, Poland.
Shosuke ItoInstitute for Melanin Chemistry, Fujita Health University, Toyoake 470-1192, Aichi, Japan.ORCID 0000-0001-9182-5144
Kazumasa WakamatsuInstitute for Melanin Chemistry, Fujita Health University, Toyoake 470-1192, Aichi, Japan.ORCID 0000-0003-1748-9001
Andrzej ZadloDepartment of Biophysics, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387 Krakow, Poland.
Marcin MajkaDepartment of Transplantation, Faculty of Clinical Immunology and Transplantation, Institute of Pediatrics, Collegium Medicum Jagiellonian University, Wielicka 265, 30-663 Krakow, Poland.ORCID 0000-0002-0429-681X
Tadeusz SarnaDepartment of Biophysics, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387 Krakow, Poland.ORCID 0000-0002-7693-5756
Michal SarnaDepartment of Biophysics, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387 Krakow, Poland.ORCID 0000-0001-9306-7965

Funding

National Science Center of Poland OPUS-2021/43/B/ST4/03255
6 · The paper itself

Abstract

Although melanin is viewed as a natural sunscreen that protects pigmented cells against the adverse effects of solar radiation, recent studies have demonstrated that, under certain conditions, the pigment can actually contribute to light-induced oxidative damage of the cells. However, the main issue with such studies is finding natural pigments without photooxidative modifications. Recently, melanin obtained from melanocytes, generated from human induced pluripotent stem cells (hiPSC-Mel), was suggested as a promising source of the pigment without significant photooxidation. Although different studies have demonstrated the feasibility of the above-mentioned technique to obtain melanin-producing cells, no thorough analysis of the physicochemical properties of the pigment has been performed. To address this issue, we examined the key physicochemical parameters, including the aerobic photoreactivity of melanin isolated from hiPSC-Mel and compared them with those of melanin from other known sources of the pigment, such as bovine retinal pigment epithelium (bRPE) and phototype V (PT-V) hair. Electron paramagnetic resonance (EPR) spectroscopy, dynamic light scattering, UV-Vis absorption and HPLC analysis of melanin degradation products were used. The ability of the examined melanins to photogenerate reactive oxygen species was determined by employing EPR oximetry, EPR spin-trapping and time-resolved singlet oxygen phosphorescence. Although the results of such measurements demonstrated that melanin obtained from hiPSC-Mel exhibited the physicochemical properties typical for eumelanin, a contribution from pheomelanin with a substantial presence of benzothiazine subunits, was also evident. Importantly, the hiPSC-Mel pigment had significantly lower photoreactivity compared to bRPE melanin and PT-V hair melanin. Our findings indicate that hiPSC-Mel could be an excellent source of high-quality pigment for photoprotection studies.

Indexed as

Induced Pluripotent Stem CellsMelaninsMelanocytesAnimalsCattleElectron Spin Resonance SpectroscopyHairHumansLightReactive Oxygen SpeciesRetinal Pigment EpitheliumMelaninsReactive Oxygen SpeciesEPReumelaninhiPSC-Melmelaninmelanocytesphotoreactivityphysicochemical propertiesROSsinglet oxygensuperoxide anion

Identifiers

PMID40362359
PMCPMC12071629

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.